Bailey John E. (Jack) Jr. - Insider Non-Derivative Transactions at G1 Therapeutics, Inc. (GTHX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 18, 2024, Bailey John E. (Jack) Jr.'s relationship to G1 Therapeutics, Inc. (GTHX) is Director,Officer (President and CEO), and currently has 731,074 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other GTHX insiders.

Data Source: SEC.
Bailey John E. (Jack) Jr. - Insider Non-Derivative Transactions of GTHX Common Stock
Bailey John E. (Jack) Jr. - Insider Non-Derivative Transactions at GTHX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 19, 2024 U -- (Common Stock) 196287 0 0
Sep 19, 2024 Disposition -- (Common Stock) 534787 0 196287
Sep 19, 2024 Acquisition -- (Common Stock) 181400 0 731074
Jul 6, 2024 Sell -- (Common Stock) 7662 2.51 549674
Jul 2, 2024 Acquisition -- (Common Stock) 105000 0 557336
May 14, 2024 Sell -- (Common Stock) 37258 4.79 452336
Jan 4, 2024 Sell -- (Common Stock) 9094 3.12 489594
Jan 4, 2024 Sell -- (Common Stock) 2592 3.12 498688
Jan 4, 2024 Acquisition -- (Common Stock) 100700 0 501280
Jan 3, 2024 Sell -- (Common Stock) 32983 3.27 400580
Jul 6, 2023 Sell -- (Common Stock) 2719 2.45 433563
May 11, 2023 Acquisition -- (Common Stock) 160000 0 436282
Jan 5, 2023 Sell -- (Common Stock) 5607 5.58 276282
Jan 4, 2023 Sell -- (Common Stock) 32019 5.85 281889
Jan 4, 2023 Acquisition -- (Common Stock) 80700 0 313908